Anastrozole Tablet, Film Coated
Product Images NDC 72789-575

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Anastrozole (NDC 72789-575). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pd-rx Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (72789575)

Image (72789575)
This text provides information on a medication called Anastrozole, which comes in the form of film-coated tablets containing 1 mg of the active ingredient. The product is manufactured by PD-Rx Pharmaceuticals, Inc. and should be stored at room temperature. It is important to keep this medication out of the reach of children. The usual dosage instructions and additional prescribing details can be found in the accompanying information. The GTIN code for this product is 00372789575155, and the expiration date is 08/2023 with LOT number 99799. For any product inquiries, contact PD-Rx Pharmaceuticals, Inc.*
FDA Label Image

Anastrozole-fig1 (Anastrozole Fig1)

FDA Label Image

Anastrozole-fig2 (Anastrozole Fig2)

FDA Label Image

Anastrozole-fig3 (Anastrozole Fig3)

Anastrozole-fig3 (Anastrozole Fig3)
This is a data table showing the TIME TO EVENT in months for a randomized treatment with Anastozole and Tamoxifen. The number of patients at risk is provided for each treatment group at different time intervals. The text mentions that the vertical axis has been truncated to enhance the clarity of the Kaplan-Meier curves.*
FDA Label Image

Anastrozole-fig4 (Anastrozole Fig4)

FDA Label Image

Anastrozole-fig5 (Anastrozole Fig5)

FDA Label Image

Anastrozole-fig6 (Anastrozole Fig6)

Anastrozole-fig6 (Anastrozole Fig6)
This document appears to be a progress chart showing the time to progression in months for treatments with anastrozole and tamoxifen. The number of patients at each time point is also listed to track the proportion progressing through the treatment.*
FDA Label Image

Chemical Structure (Anastrozole Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.